The Cooper Companies, Inc. (NYSE:COO) announced it will release second quarter 2014 financial results on Thursday, June 5, 2014, at 4:00 PM ET. Following the release, the Company will host a conference call and live webcast with investors and analysts at 5:00 PM ET to discuss the results and current corporate developments. The Cooper Companies, Inc. (NYSE:COO) net profit margin is 22.80% and weekly performance is 0.37%. On last trading day company shares ended up $133.22. Analysts mean target price for the company is $141.11. The Cooper Companies, Inc. (NYSE:COO) distance from 50-day simple moving average (SMA50) is 0.51%.
On 7 MAY 2014 CAS Medical Systems Inc (NASDAQ:CASM) announced receipt of U.S. Food and Drug Administration (FDA) clearance of an expanded label claim for the Company’s FORE-SIGHT ELITE® Oximeters for use in non-cerebral tissue of adults. This clearance will permit FORE-SIGHT ELITE oximeters to be marketed to clinicians to determine oxygen saturation of hemoglobin in musculoskeletal applications, and follows CASMED’s submission of a 510(k) application.CAS Medical Systems Inc (NASDAQ:CASM) shares fell -2.75% in last trading session and ended the day on $2.12. CASM Gross Margin is 34.20% and its return on assets is -73.10%. CAS Medical Systems Inc (NASDAQ:CASM) quarterly performance is -2.75%.
Baxano Surgical Inc (NASDAQ:BAXS) announced its financial results for the first quarter ended March 31, 2014. Revenue was $4.4 million in the first quarter of 2014, representing a 42.4% increase from revenue of $3.1 million in the first quarter of 2013. Domestic revenue was $4.3 million in the first quarter of 2014, compared to $2.6 million in the first quarter of 2013 and international revenue was $0.1 million in the first quarter of 2014, compared to $0.5 million in the first quarter of 2013. Revenue contributed in the first quarter of 2014 by the Baxano, Inc. products, which were acquired on May 31, 2013, was $2.5 million. Baxano Surgical Inc (NASDAQ:BAXS) shares moved up 2.16% in last trading session and was closed at $0.710, while trading in range of $0.68 – $0.75. Baxano Surgical Inc (NASDAQ:BAXS) year to date (YTD) performance is -29.70%.
AtriCure Inc. (NASDAQ:ATRC) meeting to be held in Minneapolis on may 21 and in chicago on May 22.AtriCure Inc. (NASDAQ:ATRC) ended the last trading day at $15.60. Company weekly volatility is calculated as 4.81% and price to cash ratio as 5.39. AtriCure Inc. (NASDAQ:ATRC) showed a positive weekly performance of 1.04%.
Daxor Corporation (NYSEMKT:DXR) weekly performance is -1.56%. On last trading day company shares ended up $8.22. Analysts mean target price for the company is $30.00. Daxor Corporation (NYSEMKT: DXR) distance from 50-day simple moving average (SMA50) is -0.20%.